LIBRATE 25MG TABLET contains chlordiazepoxide, which belongs to the group of medicines known as benzodiazepine anxiolytics. It is used for the short-term management of severe anxiety. It is also used for the management of muscle spasms of varied causes, for the management of symptoms of sudden alcohol withdrawal and the management of insomnia associated with anxiety (restless, uneasy, feeling of fear, etc.). It can also be used as an adjunct for stress reduction in insomnia, pre-and post-operative apprehension, tension headache, premenstrual tension and stress reduction in functional gastrointestinal, cardiovascular, gynaecological and dermatological disorders.
LIBRATE 25MG TABLET is not recommended for use in patients suffering from myasthenia gravis (severe muscle weakness), patients suffering from acute narrow-angle glaucoma (type of eye disease due to damage to the optic nerve), patients suffering from severe liver disease, patients suffering from severe respiratory disease such as sleep apnoea syndrome (severe breathing difficulty while sleeping), in patients suffering from spinal or cerebral ataxia (loss of control over body movements) and in patients suffering from mental disorders such as personality disorder, depression, hallucinations and delusions, etc.
LIBRATE 25MG TABLET should be used with caution in patients suffering from psychiatric disorders such as schizophrenia (a mental illness in which a person’s ability to think, feel and behave is altered), depression, delirium, senile dementia, mania, in patients who have a history of alcohol or drug abuse, in patients who are suffering from kidney problems and liver problems, in patients suffering from blood disorders such as blood dyscrasias, if you have or ever had suicidal thoughts and in patients who have or have had seizures/fits.
LIBRATE 25MG TABLET should not be used in pregnant women unless necessary. LIBRATE 25MG TABLET is not recommended for use by breastfeeding women as it may pass through...
No content available
